The lncRNA HULC promotes CML cell proliferation by regulating the PI3K/AKT pathway and its expression is positively correlated with clinical stage of CML (Lu et al., 2017). The gene discussed is AKT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.